www.fdanews.com/articles/72788-cryolife-presents-positive-results-for-synergraft-av-device
CryoLife Presents Positive Results for SynerGraft AV Device
May 27, 2005
CryoLife, a biomaterials and biosurgical device company, announced that positive results of its SynerGraft Model 100, a bovine ureter used for arteriovenous (AV) access in dialysis patients, were presented at the Fourth International Congress of the Vascular Access Society in Berlin, Germany. The data showed freedom from infection of 94 percent and secondary patency of 79 percent at one year.
()a href="http://menafn.com/qn_news_story.asp?StoryId=CqPvjWbWbmtq2Cdu3otC" target="_blank">MENAFN